Stempeutics Research Pvt. Ltd. products

Stempeucel® is our flagship product. It is an on-demand, off-the-shelf product based on pooled, allogeneic Mesenchymal Stromal Cells (MSC) derived from bone marrow of healthy, adult volunteers. In August 2020, Drug Controller General of India (DCGI) has granted manufacturing and marketing approval of Stempeucel® product for the treatment of CLI due to Buerger’s Disease and CLI due to Atherosclerotic Peripheral Arterial Disease. Stempeucel® becomes the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved Globally for CLI indication. Stempeucel® is being developed for the treatment of Knee Osteoarthritis (OA), Diabetic Foot Ulcer (DFU), Perianal Fistula (PAF) and Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 pneumonia.

A novel anti-ageing serum with stem cell derived bioactive factors which promote firm, well moisturized and brighter skin with reduced blemishes and fine lines.

A hair serum prepared from the bio-active medium of stem cells that promotes scalp hair growth and reduces hair fall.

An under-eye dark circle reduction serum prepared from the bio-active medium of stem cells that reduces under eye dark circles, rehydrates and soothes the skin.